Nureca Ltd (NURECA) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1003462,
    "name": "Nureca",
    "stock_name": "Nureca",
    "full_name": "Nureca Ltd",
    "name_url": "stocks-analysis/nureca",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "229.90",
    "chg": -0.1,
    "chgp": "-0.04%",
    "dir": -1,
    "prev_price": "230.00",
    "mcapval": "219.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 543264,
    "symbol": "NURECA",
    "ind_name": "Healthcare Services",
    "ind_code": 26,
    "sector_id": 35,
    "indexname": "India SENSEX",
    "isin": "INE0DSF01015",
    "curr_date": "Jun 11, 03:30 PM",
    "curr_time": "01:35 AM",
    "last_traded_at": "Jun 11, 03:30 PM IST",
    "bse_nse_vol": "8.09 k",
    "exc_status": "Active",
    "traded_date": "Jun 11, 2026",
    "traded_date_str": "2026 06 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/nureca-1003462-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Nureca Ltd is Rated Strong Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nureca-ltd-is-rated-strong-sell-by-marketsmojo-4046504",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/NurecaLtd_mojoScore_4046504.png",
        "date": "2026-06-11 10:10:22",
        "description": "Nureca Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 30 May 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 11 June 2026, providing investors with the latest insights into the stock’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Nureca Ltd Valuation Shifts Signal Heightened Risk Amid Market Downturn",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/nureca-ltd-valuation-shifts-signal-heightened-risk-amid-market-downturn-4029548",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/NurecaLtd_valuationdot_4029548.png",
        "date": "2026-06-02 08:05:39",
        "description": "Nureca Ltd, a micro-cap player in the healthcare services sector, has seen its valuation parameters deteriorate significantly, with its price-to-earnings (P/E) ratio soaring to 109.5 and price-to-book value (P/BV) hovering at 1.15. This shift from an expensive to a risky valuation grade coincides with a steep 14.85% drop in its share price on 2 June 2026, signalling growing investor concerns amid underwhelming financial performance and challenging market conditions."
      },
      {
        "title": "Nureca Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nureca-ltd-is-rated-strong-sell-4024360",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NurecaLtd_mojoScore_4024360.png",
        "date": "2026-05-31 10:10:18",
        "description": "Nureca Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 30 May 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 31 May 2026, providing investors with the most up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Nureca Q4 FY26: Sharp Loss Reversal Raises Serious Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/nureca-q4-fy26-sharp-loss-reversal-raises-serious-concerns-4024732",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/Nureca_quaterlyResult_4024732.png",
        "date": "2026-05-30 23:55:10",
        "description": "Nureca Ltd., a micro-cap home healthcare and wellness products company with a market capitalisation of ₹268.00 crores, reported a concerning fourth quarter for FY26, posting a net loss of ₹6.09 crores compared to a profit of ₹3.73 crores in the previous quarter—a dramatic reversal that has raised red flags amongst investors. The stock, trading at ₹280.90 as of May 29, 2026, remains under pressure despite a modest 1.78% gain in the most recent trading session, reflecting broader concerns about the company's operational sustainability and profitability trajectory."
      },
      {
        "title": "Nureca Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nureca-ltd-is-rated-sell-4000674",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NurecaLtd_mojoScore_4000674.png",
        "date": "2026-05-20 10:10:56",
        "description": "Nureca Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 Apr 2026. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the stock’s current position as of 20 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Nureca Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nureca-ltd-is-rated-sell-by-marketsmojo-3982704",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NurecaLtd_mojoScore_3982704.png",
        "date": "2026-05-09 10:10:36",
        "description": "Nureca Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 Apr 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 09 May 2026, providing investors with the most up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Nureca Ltd Upgraded to Sell by MarketsMOJO on Technical Improvements",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nureca-ltd-upgraded-to-sell-by-marketsmojo-on-technical-improvements-3965958",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/NurecaLtd_mojoScore_3965958.png",
        "date": "2026-04-28 08:54:00",
        "description": "Nureca Ltd, a micro-cap player in the Healthcare Services sector, has seen its investment rating upgraded from Strong Sell to Sell as of 27 Apr 2026. This change reflects a nuanced shift in the company’s technical outlook despite persistent challenges in its long-term fundamentals and valuation metrics. The upgrade is primarily driven by improvements in technical indicators, while financial trends and quality scores remain mixed, prompting a cautious stance among investors."
      },
      {
        "title": "Nureca Ltd Downgraded to Strong Sell Amid Technical Weakness and Valuation Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nureca-ltd-downgraded-to-strong-sell-amid-technical-weakness-and-valuation-concerns-3955379",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/NurecaLtd_mojoScore_3955379.png",
        "date": "2026-04-21 08:45:08",
        "description": "Nureca Ltd, a micro-cap player in the Healthcare Services sector, has seen its investment rating downgraded from Sell to Strong Sell as of 20 Apr 2026. This shift reflects deteriorating technical indicators, expensive valuation metrics, and weak long-term fundamental trends despite recent positive quarterly financial results."
      },
      {
        "title": "Nureca Ltd Investment Rating Upgraded to Sell on Technical and Financial Developments",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nureca-ltd-investment-rating-upgraded-to-sell-on-technical-and-financial-developments-3948644",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/NurecaLtd_mojoScore_3948644.png",
        "date": "2026-04-16 08:42:31",
        "description": "Nureca Ltd, a micro-cap player in the Healthcare Services sector, has seen its investment rating upgraded from Strong Sell to Sell as of 15 April 2026. This change reflects a nuanced shift in the company’s technical outlook despite persistent challenges in its fundamental financial metrics. The upgrade is driven primarily by improvements in technical indicators, while valuation and financial trends present a mixed picture for investors."
      }
    ],
    "total": 268,
    "sid": "1003462",
    "stock_news_url": "https://www.marketsmojo.com/news/nureca-1003462"
  },
  "announcements": [
    {
      "caption": "Nureca Limited Has Informed The Exchange Regarding No Change In The Aggregate Shareholding Of The Promoter And Promoter Group Of The Company Pursuant To Inter Se Transfer Of Shares.",
      "datetime": "10-Jun-2026",
      "details": "Nureca Limited has informed the Exchange regarding no change in the aggregate shareholding of the Promoter and Promoter Group of the Company pursuant to inter se transfer of shares.",
      "source": "BSE"
    },
    {
      "caption": "Nureca Limited Has Informed The Exchange Regarding Disclosure Under Regulation 7(2) Of SEBI (PIT) Regulations 2015",
      "datetime": "10-Jun-2026",
      "details": "Nureca Limited has informed the exchange regarding disclosure under Regulation 7(2) of SEBI(PIT) Regulations 2015.",
      "source": "BSE"
    },
    {
      "caption": "Nureca Limited Has Informed The Exchange Regarding Disclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations 2015 (PIT Regulations)",
      "datetime": "09-Jun-2026",
      "details": "Nureca Limited has informed the exchange regarding Disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 (PIT Regulations)",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Nureca Ltd has declared <strong>30%</strong> dividend, ex-date: 24 Feb 22",
          "dt": "2022-02-24",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Nureca Ltd is Rated Strong Sell by MarketsMOJO

2026-06-11 10:10:22

Nureca Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 30 May 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 11 June 2026, providing investors with the latest insights into the stock’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article

Nureca Ltd Valuation Shifts Signal Heightened Risk Amid Market Downturn

2026-06-02 08:05:39

Nureca Ltd, a micro-cap player in the healthcare services sector, has seen its valuation parameters deteriorate significantly, with its price-to-earnings (P/E) ratio soaring to 109.5 and price-to-book value (P/BV) hovering at 1.15. This shift from an expensive to a risky valuation grade coincides with a steep 14.85% drop in its share price on 2 June 2026, signalling growing investor concerns amid underwhelming financial performance and challenging market conditions.

Read full news article

Nureca Ltd is Rated Strong Sell

2026-05-31 10:10:18

Nureca Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 30 May 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 31 May 2026, providing investors with the most up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Nureca Q4 FY26: Sharp Loss Reversal Raises Serious Concerns

2026-05-30 23:55:10

Nureca Ltd., a micro-cap home healthcare and wellness products company with a market capitalisation of ₹268.00 crores, reported a concerning fourth quarter for FY26, posting a net loss of ₹6.09 crores compared to a profit of ₹3.73 crores in the previous quarter—a dramatic reversal that has raised red flags amongst investors. The stock, trading at ₹280.90 as of May 29, 2026, remains under pressure despite a modest 1.78% gain in the most recent trading session, reflecting broader concerns about the company's operational sustainability and profitability trajectory.

Read full news article

Nureca Ltd is Rated Sell

2026-05-20 10:10:56

Nureca Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 Apr 2026. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the stock’s current position as of 20 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Nureca Ltd is Rated Sell by MarketsMOJO

2026-05-09 10:10:36

Nureca Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 Apr 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 09 May 2026, providing investors with the most up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Nureca Ltd Upgraded to Sell by MarketsMOJO on Technical Improvements

2026-04-28 08:54:00

Nureca Ltd, a micro-cap player in the Healthcare Services sector, has seen its investment rating upgraded from Strong Sell to Sell as of 27 Apr 2026. This change reflects a nuanced shift in the company’s technical outlook despite persistent challenges in its long-term fundamentals and valuation metrics. The upgrade is primarily driven by improvements in technical indicators, while financial trends and quality scores remain mixed, prompting a cautious stance among investors.

Read full news article

Nureca Ltd Downgraded to Strong Sell Amid Technical Weakness and Valuation Concerns

2026-04-21 08:45:08

Nureca Ltd, a micro-cap player in the Healthcare Services sector, has seen its investment rating downgraded from Sell to Strong Sell as of 20 Apr 2026. This shift reflects deteriorating technical indicators, expensive valuation metrics, and weak long-term fundamental trends despite recent positive quarterly financial results.

Read full news article

Nureca Ltd Investment Rating Upgraded to Sell on Technical and Financial Developments

2026-04-16 08:42:31

Nureca Ltd, a micro-cap player in the Healthcare Services sector, has seen its investment rating upgraded from Strong Sell to Sell as of 15 April 2026. This change reflects a nuanced shift in the company’s technical outlook despite persistent challenges in its fundamental financial metrics. The upgrade is driven primarily by improvements in technical indicators, while valuation and financial trends present a mixed picture for investors.

Read full news article

View All News